Sun J, Liu L, Chen J, Wang Z, et al. Zanubrutinib, lenalidomide, and rituximab (ZR2 regimen) for HIV-associated diffuse large B-cell lymphoma: a real-world analysis from China. AIDS 2023;37:1909-1911.
PMID: 37646591